Enzyme vs Yield Basis — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Yield Basis trades at Rp1,430 (market cap Rp226,28M, Rp58,38M 24h volume). The key difference: Yield Basis is the larger of the two by market cap, and Yield Basis's supply is capped (157,5M / 1B YB (16%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Yield Basis for 6 Days on average.
| MLN | YB | |
|---|---|---|
Market Cap | Rp134,13M | Rp226,28M |
Volume (24h) | Rp104,56M | Rp58,38M |
Circulating Supply | 3,3M MLN | 157,5M / 1B YB (16%) |
Typical Hold Time | 29 Days | 6 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Yield Basis (YB) cryptocurrency shows bullish momentum with current price at Rp1,436.1 and market cap of Rp223.21 million. Technical indicators signal overall bullish sentiment with strong moving average support, though RSI levels suggest potential overbought conditions. The token maintains a 16% circulation rate with average hold time of 6 days, indicating active trading. Recent market activity shows strong technical positioning despite limited fundamental developments in the protocol ecosystem.
Overall outlook remains cautiously optimistic with technical strength but requires monitoring of overbought signals. Key opportunities include continued momentum if support levels hold, while major risks involve potential correction from elevated RSI levels and limited fundamental catalyst development. Investors should watch for protocol updates and increased network adoption to sustain current trajectory.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →YieldBasis is a DeFi protocol built on Curve Finance that enables users to earn yield on assets like Bitcoin while minimizing impermanent loss. It uses a constant 2× compounding leverage model to help LP positions track the underlying asset price 1:1. The YB token supports governance through a vote-escrowed (veYB) model and allows holders to share in protocol revenue.
Read more on YB →